MAPT and amyloidosis: While some reports suggested that higher CR was associated with attenuated decline in CSF Aβ and hippocampal volume, other investigations found no relationship between CR proxies and changes in amyloid burden, medial temporal lobe atrophy, fluorodeoxyglucose (FDG) metabolism, or CSF tau and p-tau levels [106,107].